CDIB BioScience Ventures

Overview

CDIB BioScience Ventures (CBVM) is a life science venture management company with operations in the United States and Taiwan. The majority of the management team was spun off from China Development Industrial Bank (CDIB) in 2001, one of the largest investment banks in Asia. CDIB remains a minor investor in the fund. Over the past decade, the team has invested in over 50 biotech companies globally, with the majority successfully listing on global stock market exchanges or being acquired. CBVM focuses on late-stage venture investments in the biotechnology and life sciences sectors. Their portfolio includes companies such as Crown Bioscience, which raised $28.8 million in Series C funding in 2011, and Advanced BioHealing, which secured $4.5 million in Series C funding in 2007. The firm operates with a global perspective, leveraging its presence in both the United States and Taiwan to identify and support promising life science ventures. With a strong track record of successful investments, CBVM continues to play a significant role in the life science venture capital landscape, bridging opportunities between the United States and Taiwan. Their strategic approach combines financial support with valuable business and operational insights, aiming to create value for both investors and portfolio companies in the dynamic biotechnology sector.

Investment Focus

• Late Stage Venture
• Biotechnology
• Life Sciences

Portfolio Companies